✦ LIBER ✦

Successful treatment of a patient with postpartum factor VIII inhibitor with recombinant human interferon α 2a

✍ Scribed by Dr. R. Schwerdtfeger; G. Hintz; D. Huhn

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 367 KB
Volume: 37
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830370311

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful use of recombinant factor VII

Successful use of recombinant factor VIIa for emergency fasciotomy in a patient with hemophilia A and high-titer inhibitor unresponsive to factor VIII inhibitor bypassing activity

✍ Raymond G. Watts 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 1 views

Acquired factor VIII inhibitor in patien

Acquired factor VIII inhibitor in patients with hepatitis C virus infection and the role of interferon-α: A case report

✍ Zwi A. Schreiber; Norbert Bräu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

Successful treatment with recombinant fa

Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease

✍ Philip W. Friederich; Peter C. Wever; Ernest Briët; Cornelis J. Doorenbos; Marce 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 21 KB 👁 2 views

Successful treatment of high titer inhib

Successful treatment of high titer inhibitors in mild hemophilia A with avoidance of factor VIII and immunosuppressive therapy

✍ Daniel Robbins; Roshni Kulkarni; Renuka Gera; Ajovi B. Scott-Emuakpor; Kathy Bos 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Treatment of advanced medullary thyroid

Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon α-2b and octreotide

✍ Giovanni Lupoli; Edvige Cascone; Francesco Arlotta; Giovanni Vitale; Luigi Celen 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 1 views

## BACKGROUND. The medical treatment of advanced medullary thyroid carcinoma (MTC) is still questionable. Results of chemotherapy are disappointing with almost no curative responses, few partial responses, and many side-effects. A recent report has suggested the activity of combination recombinant

Use of recombinant activated factor VII

Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor

✍ B. Gail Macik; John Hohneker; H. R. Roberts; Anne M. Griffin 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 1 views